Tuesday, March 21, 2023
No Result
View All Result
  • Media
Support Us
Macdonald-Laurier Institute
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
    • Women’s History Month Fundraiser
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Annual Reports
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
    • Women’s History Month Fundraiser
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Annual Reports
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media
No Result
View All Result
Macdonald-Laurier Institute

Time for the PMPRB to go: Nigel Rawson and Brett Skinner in the Hill Times

June 18, 2021
in Columns, Domestic Policy Program, Health, In the Media, Latest News
Reading Time: 5 mins read
A A

The PMPRB has abused its independence. The functional purpose of the PMPRB is no longer relevant, write Nigel Rawson and Brett Skinner in the Hill Times. 

By Nigel Rawson and Brett Skinner, June 18, 2021

Since its establishment in 1987, the Patented Medicine Prices Review Board (PMPRB), a quasi-judicial federal tribunal, has regulated prices of patented medicines. In 2017, the Liberal federal government announced it was going to reduce the prices of new medicines by introducing new PMPRB regulations.

Over the last four years, the biopharmaceutical industry, patient groups and others have voiced strong opposition to the proposed changes. As more detail was provided, the concern and hostility has increased. The PMPRB, which previously was little-known even by the parliamentarians to whom it reports, has received much scrutiny of late.

Having been postponed twice, the new regulations are due to be implemented on July 1, 2021. The latest delay was allegedly to allow more time for manufacturers to adjust to the changes during the COVID-19 pandemic. The real reason for the latest postponement is likely Federal Court and Quebec Superior Court decisions striking down the PMPRB’s new requirement for manufacturers to report details of confidential rebates offered to insurers.

In 2020, after failing to engage Ottawa, multiple global drug developers determined they had no alternative but to go to court to fight the new price controls. Quebec has now joined the opposition and is intervening in an appeal arguing that the Patent Act is not a tool for price regulation and that the new rules trespass into provincial jurisdiction

Why the profound concern from multiple stakeholders? The PMPRB claims prices will only be reduced modestly, whereas independent estimates from case studies and other evaluations indicate the required price reductions will be large and at a level unsustainable for manufacturers. This will lead to drug developers reducing investment in research, development, and manufacturing in Canada and delaying launching innovative medicines or deciding not to launch them here at all.

The PMPRB is clearly annoyed by opposition to the regulation changes. According to an internal document made public by an access to information request from Conservative MP Tom Kmiec, the PMPRB believes “opponents of the reforms … are spreading disinformation through organized public relations campaigns.” To combat “the industry’s ongoing disinformation campaign,” the PMPRB developed its own communication plan.

It will leverage social media accounts of the PMPRB, its chairperson and its senior staff, as well as webinars, videos, kits for Members of Parliament, and outreach to supportive stakeholders of the reforms (this appears to be code for anti-industry activists. A total of $56,000 of taxpayers’ money has been allocated for these activities. The communication plan highlights how the PMPRB views the industry it regulates when it states “they are knowingly disseminating false information.”

The PMPRB is also targeting patient groups. The Best Medicines Coalition (BMC), a national alliance of 29 patient organizations with a goal of equitable and consistent access for Canadians to safe and effective medicines that improve patient outcomes, wrote to Prime Minister Justin Trudeau in May concerned that the communication plan calls into question the PMPRB’s impartiality, objectivity and capability to perform its responsibilities as a regulator and conduct productive discussions with patient groups. BMC believes the content and tone seriously undermine Ottawa’s attempts to integrate patients’ concerns into the new regulatory regime, creating an environment of distrust.

Responding to BMC’s letter, the PMPRB’s chairperson stated he is ultimately responsible for all aspects of the board’s operations, including its communication plan, which he and the other board members vetted and approved. He is extremely disappointed by the level of vitriol and invective directed at the board and its public servant staff in social media and elsewhere by members of the patient advocacy community and requests BMC members to treat the PMPRB and its staff with the same respect they wish to be shown.

It’s extremely difficult to respect an organization that regards the industry it regulates and the patients it claims to be protecting with such disdain. For example, the access to information request also brought to light an email from the PMPRB’s director of policy and economic analysis to her colleagues stating that “industry has been sucking Canada for decades.”

As employees of a federal regulatory agency, PMPRB senior staff and board members are expected to be politically neutral. Elected officials make policy. Public servants are there only to advise and implement decisions made by politicians. Yet, it was the PMPRB that self-initiated the “updating” of its own regulatory framework in 2015. This was followed by staff-led crafting of its new regulations. The PMPRB then published several internally-drafted discussion papers justifying the changes with exaggerated and misleading claims about a health-care sustainability crisis caused by the prices of patented medicines. The Board has hosted several consultations in which it totally ignored evidence that disputed its interpretation of the facts, challenged its assumptions, or contradicted its policy logic. Now it wants to spend taxpayers’ money on a communication campaign to drive its agenda with parliamentarians.

The PMPRB has abused its independence. The functional purpose of the PMPRB is no longer relevant. Public and private insurers have the capacity to negotiate substantial discounts below regulated prices. In fact, Ontario’s auditor general reported that the province’s public drug plan obtained rebated prices averaging 36 per cent below the maximum allowed by the PMPRB for patented medicines.

It’s time for Parliament to revoke the PMPRB’s mandate.

Nigel Rawson is an independent researcher in Saskatoon, Sask., and an affiliate scholar with the Canadian Health Policy Institute. Brett Skinner is CEO of the Canadian Health Policy Institute in Toronto.

Tags: Health PolicyhealthcareNigel RawsonPMPRB
Previous Post

That ’70s Show – the stagflation rerun: Jack Mintz in the Financial Post

Next Post

A letter from an intergenerational survivor: Chris Sankey for Inside Policy

Related Posts

Oaths, trust and Canadian democracy: Stephen Van Dine and Karl Salgo for Inside Policy
Inside Policy

Oaths, trust and Canadian democracy: Stephen Van Dine and Karl Salgo for Inside Policy

March 17, 2023
Preparing for the Foreign Threats to Canadian Democracy: Straight Talk with Richard Fadden
Inside Policy

Canada and Japan’s common miscalculation in cyberspace: Koichiro Komiyama for Inside Policy

March 15, 2023
Defending against foreign interference in our elections: Marcus Kolga for Inside Policy
Columns

As Ottawa balks at an election interference inquiry, public trust in our democracy is draining away: Marcus Kolga in the Globe and Mail

March 15, 2023
Next Post
A letter from an intergenerational survivor: Chris Sankey for Inside Policy

A letter from an intergenerational survivor: Chris Sankey for Inside Policy

Macdonald-Laurier Institute

323 Chapel Street, Suite #300
Ottawa, Ontario
K1N 7Z2 Canada

613.482.8327

info@macdonaldlaurier.ca
MLI directory

Follow us on

Newsletter Signup

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

Inside Policy Magazine

  • Current Issue
  • Back Issues
  • Advertising
  • Inside Policy Blog
  • Privacy Policy

© 2021 Macdonald-Laurier Institute. All Rights reserved.

No Result
View All Result
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
    • Women’s History Month Fundraiser
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Annual Reports
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media

© 2021 Macdonald-Laurier Institute. All Rights reserved.